Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05758714 · ClinicalTrials.gov registry record
Effects of Transportation Choices on Commuter Health
A clinical trial, sponsored by UConn Health.
- Completed
- Registry status
- 65
- Enrollment target
NCT05758714: Completed study, sponsored by UConn Health.
NCT05758714 is a clinical trial that has completed, run by UConn Health. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05758714 has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
The primary project objective is to investigate how an individual's choices influence personal exposures to traffic-related air pollutants (TRAPs) and the corresponding acute health effects. TRAPs are a complex mixture of particulate and gaseous pollutants that vary considerably spatially and temporally. There is increasing evidence that TRAPs inflict a broad range of deleterious health effects in both health-compromised and healthy individuals, and it has been reported that traffic pollutants may cause up to half of all air pollution-related mortalities. Despite the burden from such widespread, involuntary exposures, few studies have examined the magnitude of personal exposures due to commuting exposures. Most commuters travel to and from work during two peak travel periods, which occur during weekday mornings and evenings. Public transportation, bicycling, and walking have been promoted as ways to reduce air pollution by reducing the vehicle fleet, yet few studies have examined how exposures are modified due to an intentional change in the time of commute or the subsequent health effects.
Primary Outcome
Systolic and Diastolic measured on the non-dominant arm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2023-02-06 |
| Est. Completion | 2025-04-24 |
What the finished NCT05758714 record still lists
NCT05758714 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05758714 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05758714 about?
NCT05758714 is a clinical study titled "Effects of Transportation Choices on Commuter Health". The primary project objective is to investigate how an individual's choices influence personal exposures to traffic-related air pollutants (TRAPs) and the corresponding acute health effects. TRAPs are a complex mixture of particulate and gaseous pollutants that vary considerably spatially and tempor...
What is the current status of trial NCT05758714?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2023-02-06. Estimated completion is 2025-04-24.
Who is sponsoring clinical trial NCT05758714?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI